First COVID-19 Vaccine Human Trial Finds It Is Safe, Induces Immune Response
New Delhi: The first COVID-19 vaccine to reach phase I clinical trial is safe, well-tolerated, and capable of generating an immune response against the novel coronavirus in humans, says a…
Share